Clinical Trial Update: A 2-Part Study to Assess Efficacy, Safety and Tolerability of BMB-101 for the Treatment of Patients With Prader-Willi Syndrome. [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study evaluating the efficacy, safety, and tolerability of BMB-101 for Prader-Willi Syndrome, currently not yet r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prader-willi Syndrome

Drugs mentioned

• BMB-101

Snippet

Sponsor: Bright Minds Biosciences Pty Ltd | Conditions: Prader-Willi Syndrome | Phase 2 | Status: NOT_YET_RECRUITING